Navigation Links
VIA Pharmaceuticals to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
Date:5/8/2008

SAN FRANCISCO, May 8 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that James G. Stewart, senior vice president and chief financial officer, will present a company update at the Rodman & Renshaw 5th Annual Global Healthcare Conference on Monday, May 19, 2008 at 11:50 a.m. CEST at Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco.
Interested parties may access a live audio webcast of the presentation from the investor section of the VIA website, http://www.viapharmaceuticals.com or at http://www.wsw.com/webcast/rrshq13/viap. A replay of the presentation will be archived on the VIA website for at least one week following the presentation. About VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. VIA is building a pipeline of small-molecule drugs that target a significant unmet medical need: reducing inflammation in the blood vessel wall, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke. The company's lead drug candidate, VIA-2291, is in multiple Phase 2 clinical studies in patients with cardiovascular disease. For more information, visit: http://www.viapharmaceuticals.com.


'/>"/>
SOURCE VIA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related biology technology :

1. Memory Pharmaceuticals to Announce First Quarter 2008 Results on Wednesday, May 14, 2008
2. Arena Pharmaceuticals Announces First Quarter 2008 Financial Results
3. Amylin Pharmaceuticals to Present at Bank of America Healthcare Conference
4. Jazz Pharmaceuticals, Inc. to Announce First Quarter Results on May 13, 2008
5. Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update
6. Onyx Pharmaceuticals Reports 2008 First Quarter Results
7. SGX Pharmaceuticals Schedules Teleconference and Webcast to Discuss First Quarter 2008 Results and Provide Pipeline Update
8. Israels Prestigious Presidents Conference to Feature Oramed Pharmaceuticals Revolutionary Oral Insulin Capsule
9. Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals Board of Directors
10. Keryx Biopharmaceuticals to Present at the Deutsche Bank 33rd Annual Health Care Conference
11. GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...ember 4 Azur Pharma Limited ("Azur...initive agreement with BioSante,Pharmaceuticals, ...rights to,Elestrin(TM). Elestrin is a fast drying...for the treatment of moderate to severe vasomotor ...approved by the U.S. Food and Drug,Administration...
(Date:12/4/2008)... TUSTIN, Calif., Dec. 4 ...) today announced that it will release its financi...009 on December 10, 2008 at 7:00 a.m. EST and will... results at 11:30 a.m. EST on the same day. , ...inancial results for the second quarter ended Octo...
(Date:12/4/2008)...EW, Calif., Dec. 4 Based on its re...st & Sullivan recognizes Honeywell Enraf with ...ar Award. Honeywell Enraf,s comprehensive suite of...e mixture of fuels, chemicals and other materials,...te. Honeywell Enraf,s blending equipment,s accurac...
(Date:12/4/2008)... Applied Biosystems, part of Life Te...f innovative life science research and discovery s...next-generation genomic analysis, the SOLiD™...n of the Year for 2008 by The Scientist, a leading...e industry. In making the announcement of the firs...
Breaking Biology Technology:Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM) 2Peregrine Pharmaceuticals to Report Second Quarter FY 2009 Financial Results 2Frost & Sullivan Commends Honeywell Enraf for Cutting-Edge Products and Post-Sales Support 2Frost & Sullivan Commends Honeywell Enraf for Cutting-Edge Products and Post-Sales Support 3 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 2 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 3 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 4 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 5
... for amplification of long targets (up to 35 k... 002 100 units , , , , , , ...d containing Taq and Pwo DNA Polymerase and anothe...LUS PCR System also includes , an optimize... a human control DNA (template DNA plus beta-gl...
... , , , , Which of the follow...late/starting material: , , , , ,... , , , , ...<a , href="http://www.roche-app..., have very little starting material ...
... , , , , , , ...size of template , Temperature optimum..., Ion require- , ment ,... RT and DNA Pol. , Incorporates DIG-11...e- , verse Trans- , crip...
... for routine amplification of up to 3 kb genom...ts (1 unit/l) , , Cat. No. 1 647 68... 165 100 units (5 units/l) , Cat. No. 1 146... 432 4 x 250 units (5 units/l) , Cat. No. 1...No. 1 435 094 20 x 250 units (5 units/l) , , ...
Other Biology Technology:Expand 20 kbPLUS PCR System 2Find the optimal product for your PCR application 2Properties of Reverse Transcriptases 2Taq DNA Polymerase 2Taq DNA Polymerase 3
(Date:12/3/2008)...to forget that a dam and pond stood for 43 years o...Farm Research Station in southwestern Wisconsin. A...plants, both native and weedy, now carpet the floo...of the dam remain, and by digging into the soils o...hing them. Writing in a special issue (December) o...
(Date:12/3/2008)...5-year forest inventory report for Oregon,s privat... Oregon,s Forest Resources, 2001-2005: Five-Year F...some key findings from the report:, , Oregon,s ... Oregon,s total land area of 61 million acres. , ...cularly near urban areas. The rate of conversion h...
(Date:12/3/2008)...nography at UC San Diego returning from research e...etails of vibrant sea life and ecosystems in the G... species and marine animals previously never seen ... at unexplored depths, have revealed disturbing de...uman impacts have stretched down deeply in the gul...
(Date:12/3/2008)... gene into mouse blood cells, scientists at St. Ju...ckle cell disease pathology. In their studies, the...sentially no difference from normal mice. Although...rapy to humans presents significant technical obst...me an important treatment for the disease. , Sic...
Breaking Biology News(10 mins):Researchers examine role of soil patterns in dam restoration 2Researchers examine role of soil patterns in dam restoration 3Forest inventories in Oregon include more than trees 2Forest inventories in Oregon include more than trees 3Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 2Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 3Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 4Gene therapy corrects sickle cell disease in laboratory study 2Gene therapy corrects sickle cell disease in laboratory study 3Medicare Fee Cuts Could Devastate Rehabilitation Services Physical Therapists Warn Congress 18871 1Medicare Fee Cuts Could Devastate Rehabilitation Services Physical Therapists Warn Congress 18871 2Medicare Fee Cuts Could Devastate Rehabilitation Services Physical Therapists Warn Congress 18871 3Medicare Fee Cuts Could Devastate Rehabilitation Services Physical Therapists Warn Congress 18871 4Bill Moyers Journal to Feature California Nurses Association National Nurses Organizing Committee in Friday May 9th Episode 18866 1Bill Moyers Journal to Feature California Nurses Association National Nurses Organizing Committee in Friday May 9th Episode 18866 2Pharmos Corporation Reports 2008 First Quarter Results 5249 1Pharmos Corporation Reports 2008 First Quarter Results 5249 2Pharmos Corporation Reports 2008 First Quarter Results 5249 3Pharmos Corporation Reports 2008 First Quarter Results 5249 4Keryx Biopharmaceuticals Inc to Hold Conference Call on First Quarter 2008 Financial Results on Monday May 12 at 8 3A30 A M EDT 5244 1Keryx Biopharmaceuticals Inc to Hold Conference Call on First Quarter 2008 Financial Results on Monday May 12 at 8 3A30 A M EDT 5244 2
...And, at least for mice, it,s one that is best made...eriments designed help scientists understand the b...d his colleagues exposed female mice to odors of e...male. The females consistently preferred the scent...ggest that female mice may use, or even copy, the ...
...ege of Agriculture and Life Sciences are part of c...that have been awarded $5 million from the USDA to...s to produce higher quality, disease-resistant whe...nt of molecular research has been conducted wherei...e been used to identify genes controlling traits o...
... This emerging disease has an awkward name, vague ...ed by bacteria that live inside ticks and flatworm...Library of Science Genetics (PLoS Genetics), scien...--and discover some brilliant biology. , Led by s...IGR) and The Ohio State University (OSU), a team o...
...ntages for patients but is very difficult for the ... Amsterdam, Joris Jaspers has developed two instru...aper than with existing surgical robotics. Jaspers... Delft University of Technology. , Endoscopic oper...l for the patient and give a better cosmetic resul...
Other Biology News:When mice choose mates, experience counts 2Virginia Tech helping to develop higher quality, disease-resistant wheat varieties 2Ticks, flukes, and genomics: Emerging pathogens revealed 2Ticks, flukes, and genomics: Emerging pathogens revealed 3Cheaper and simpler keyhole surgery 2
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (R3776) or contact customer s
...inear Ion Trap Time of Flight Mass Analyzer for su...ower., Specifications:, * MS mode measurement ra...ange: 150 - 4000 m/z, * Resolution: 14,000 (1400 m...ference, * Dynamic range: 4 orders of magnitude ...
...s a pleiotropic cytokine produced by activated T c...hibits the growth of some tumour and normal cell l...sis sarcoma cell proliferation, cytokine release f...receptor expression on hepatoma cells. Mouse OSM w...
...or Prostaglandin F2α isopropyl ester (15(R)... the latanoprost-related isomer containing both a ...droxyl group at C-15. Similar to 15(S)-latanoprost...ter is a potential impurity in most commercial pre...
Biology Products: